Timing, duration, and differential susceptibility to early life adversities and cardiovascular disease risk across the lifespan: Implications for future research

• Authors: Shakira Suglia, Emory University; Allison A Appleton, State University of New York Albany; Maria E Bleil, University of Washington; Rebecca A Campo, National Heart, Lung, and Blood Institute (NHLBI); Shanta R Dube, Wingate University; Christopher P Fagundes, Rice University; Nia J Heard-Garris, Northwestern University Feinberg School of Medicine; Sara B Johnson, Johns Hopkins School of Medicine; Natalie Slopen, Harvard T.H. Chan School of Public Health; Catherine M Stoney, National Heart, Lung, and Blood Institute (NHLBI); Sarah E Watamura, University of Denver
• Journal Title: Preventive Medicine
• Volume: Volume 153
• Publisher: Elsevier | 2021-12-01, Pages 106736-106736
• Type of Work: Article | Post-print: After Peer Review
• Publisher DOI: http://doi.org/10.1016/j.ypmed.2021.106736
• Subjects: Health Sciences, Epidemiology; Biology, Biostatistics
• Keywords: Adult; Bullying; Cardiovascular Diseases; Child; Child Abuse; Humans; Life Change Events; Longevity; Risk Factors; Social Determinants of Health

Abstract

Early life adversities (ELA), include experiences such as child maltreatment, household dysfunction, bullying, exposure to crime, discrimination, bias, and victimization, and are recognized as social determinants of cardiovascular disease (CVD). Strong evidence shows exposure to ELA directly impacts cardiometabolic risk in adulthood and emerging evidence suggests there may be continuity in ELA's prediction of cardiometabolic risk over the life course. Extant research has primarily relied on a cumulative risk framework to evaluate the relationship between ELA and CVD. In this framework, risk is considered a function of the number of risk factors or adversities that an individual was exposed to across developmental periods. The cumulative risk exposure approach treats developmental periods and types of risk as equivalent and interchangeable. Moreover, cumulative risk models do not lend themselves to investigating the chronicity of adverse exposures or consider individual variation in susceptibility, differential contexts, or adaptive resilience processes, which may modify the impact of ELA on CVD risk. To date, however, alternative models have received comparatively little consideration. Overall, this paper will highlight existing gaps and offer recommendations to address these gaps that would extend our knowledge of the relationship between ELA and CVD development. We focus specifically on the roles of: 1) susceptibility and resilience, 2) timing and developmental context; and 3) variation in risk exposure. We propose to expand current conceptual models to incorporate these factors to better guide research that examines ELA and CVD risk across the life course.